1-3 of 3
Daniel Franke
Close
Sort by
Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Clinical Trials & Observations
Christian Straka, Michael Sandherr, Hans Salwender, Hannes Wandt, Bernd Metzner, Kai Hübel, Gerda Silling, Marcus Hentrich, Daniel Franke, Rainer Schwerdtfeger, Mathias Freund, Orhan Sezer, Alexander Giagounidis, Gerhard Ehninger, Wolfgang Grimminger, Andreas Engert, Günter Schlimok, Christof Scheid, Peter Hellmann, Harald Heinisch, Hermann Einsele, Axel Hinke, Bertold Emmerich
Journal: Blood
Blood (2011) 117 (7): 2121–2128.
https://doi.org/10.1182/blood-2010-06-290080
Published: 2011
Journal Articles

Bortezomib, Intravenous Cyclophosphamide and Dexamethasone (VelCD) for Previously Untreated Multiple Myeloma: An Interim Analysis of the German DSMM XIa Trial

Stefan Knop, MD, Peter Liebisch, MD, Hannes Wandt, MD, Martin Kropff, MD, Volker Kunzmann, MD, Katja Weisel, MD, Daniel Franke, MD, Monika Engelhardt, MD, Lorenz H. Truemper, MD, PhD, Nikolaus Kroeger, MD, Burkhard Hennemann, MD, Michael Pfreundschuh, MD, PhD, Martin Gramatzki, MD, Bernd Metzner, MD, Christian Peschel, MD, Herbert G. Sayer, MD, PhD, Orhan Sezer, MD, Heinz A Duerk, MD, Bernd Hertenstein, MD, Hans-Guenther Mergenthaler, MD, Hella Gollasch, MD, Hans-Heinrich Wolf, MD, Georgia Schilling, MD, Claas Frohn, MD, Hermann Einsele, MD
Journal: Blood
Blood (2008) 112 (11): 2776.
https://doi.org/10.1182/blood.V112.11.2776.2776
Published: 2008
Journal Articles

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Philipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, Christian Straka, Daniel Franke, Ralf Schmidmaier
Journal: Blood
Blood (2006) 108 (11): 5045.
https://doi.org/10.1182/blood.V108.11.5045.5045
Published: 2006